Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("DAMARAJU, Vijaya L")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 12 of 12

  • Page / 1
Export

Selection :

  • and

RENAL CONSERVATION OF FOLATES : ROLE OF FOLATE TRANSPORT PROTEINSDAMARAJU, Vijaya L; CASS, Carol E; SAWYER, Michael B et al.Vitamins and hormones. 2008, Vol 79, pp 185-202, issn 0083-6729, 18 p.Article

A study of reproducibility of guanidination-dimethylation labeling and liquid chromatography matrix-assisted laser desorption ionization mass spectrometry for relative proteome quantificationCHENGJIE JI; NAN ZHANG; DAMARAJU, Sambasivarao et al.Analytica chimica acta. 2007, Vol 585, Num 2, pp 219-226, issn 0003-2670, 8 p.Article

Cytotoxic activity of gemcitabine in cultured cell lines derived from histologically different types of bladder cancer: Role of thymidine kinase 2DAMARAJU, Swathi; DAMARAJU, Vijaya L; MOWLES, Delores et al.Biochemical pharmacology. 2010, Vol 79, Num 1, pp 21-29, issn 0006-2952, 9 p.Article

Cytotoxic activities of nucleoside and nucleobase analog drugs in malignant mesothelioma : Characterization of a novel nucleobase transport activityDAMARAJU, Deepti; DAMARAJU, Vijaya L; BRUN, Miranda et al.Biochemical pharmacology. 2008, Vol 75, Num 10, pp 1901-1911, issn 0006-2952, 11 p.Article

Two Distinct Molecular Mechanisms Underlying Cytarabine Resistance in Human Leukemic CellsJIE CAI; DAMARAJU, Vijaya L; GROULX, Normand et al.Cancer research (Baltimore). 2008, Vol 68, Num 7, pp 2349-2357, issn 0008-5472, 9 p.Article

Erlotinib, Gefitinib, and Vandetanib Inhibit Human Nucleoside Transporters and Protect Cancer Cells from Gemcitabine CytotoxicityDAMARAJU, Vijaya L; SCRIVER, Tara; MOWLES, Delores et al.Clinical cancer research (Print). 2014, Vol 20, Num 1, pp 176-186, issn 1078-0432, 11 p.Article

An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicityPRADO, Carla M. M; LIMA, Isac S. F; BARACOS, Vickie E et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 1, pp 93-101, issn 0344-5704, 9 p.Article

Interaction of fused-pyrimidine nucleoside analogs with human concentrative nucleoside transporters: High-affinity inhibitors of human concentrative nucleoside transporter 1DAMARAJU, Vijaya L; SMITH, Kyla M; MOWLES, Delores et al.Biochemical pharmacology. 2011, Vol 81, Num 1, pp 82-90, issn 0006-2952, 9 p.Article

Human concentrative nucleoside transporter 3 is a determinant of fludarabine transportability and cytotoxicity in human renal proximal tubule cell culturesELWI, Adam N; DAMARAJU, Vijaya L; KUZMA, Michelle L et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 2, pp 289-301, issn 0344-5704, 13 p.Article

Transepithelial fluxes of adenosine and 2'-deoxyadenosine across human renal proximal tubule cells: roles of nucleoside transporters hENT1, hENT2, and hCNT3ELWI, Adam N; DAMARAJU, Vijaya L; KUZMA, Michelle L et al.American journal of physiology. Renal physiology. 2009, Vol 65, Num 6, issn 1931-857X, F1439-F1451Article

Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapyDAMARAJU, Vijaya L; DAMARAJU, Sambasivarao; YOUNG, James D et al.Oncogene (Basingstoke). 2003, Vol 22, Num 47, pp 7524-7536, issn 0950-9232, 13 p.Article

Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidneyDAMARAJU, Vijaya L; ELWI, Adam N; SAWYER, Michael B et al.American journal of physiology. Renal physiology. 2007, Vol 62, Num 1, issn 1931-857X, F200-F211Article

  • Page / 1